Semnur Pharmaceuticals, Inc.(SMNR:US)
Market Cap$84.26M
Key Metrics
Price$0.37
Revenue (TTM)-
Holders Revenue (TTM)-
Gross Profit (TTM)-
Earnings (TTM)-
EBITDA (TTM)-
Op. Margin (TTM)-
Dividend Yield-
Holders Yield-
Cash on hand$103K
Total Assets$1.97M
Net Assets-$25.33M
Total Debt$19.68M
Key Metrics
Price$0.37
Revenue (TTM)-
Holders Revenue (TTM)-
Gross Profit (TTM)-
Earnings (TTM)-
EBITDA (TTM)-
Op. Margin (TTM)-
Dividend Yield-
Holders Yield-
Cash on hand$103K
Total Assets$1.97M
Net Assets-$25.33M
Total Debt$19.68M
Financials
| Name | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 |
|---|---|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 | $0 | $0 |
Cost of Revenue | - | - | - | - | - | - |
Gross Profit | - | - | - | - | - | - |
| $4.58M | $6.16M | $152.59M | $665K | $776K | $1.3M | |
| Research and Development | $1.27M | $714K | $1.14M | $187K | $235K | $233K |
| Selling, General, and Administrative | $3.31M | $5.44M | $151.45M | $478K | $541K | $1.07M |
| Other Operating Expenses | - | - | - | - | - | - |
Operating Income | -$4.58M | -$6.16M | -$152.59M | -$665K | -$776K | -$1.3M |
| - | - | - | - | - | - | |
| Non-Operating Interest Income | - | - | - | - | - | - |
| Non-Operating Interest Expense | - | - | - | - | - | - |
| Other Income/Expense | - | - | - | - | - | - |
Income Before Tax | -$4.58M | -$6.16M | -$152.59M | -$665K | -$776K | -$1.3M |
Income Tax | - | - | - | - | - | - |
Net Income | -$4.58M | -$6.16M | -$152.59M | -$665K | -$776K | -$1.3M |
Minority Interests | - | - | - | - | - | - |
Preferred Stock Dividends | - | - | - | - | - | - |
Net Income to Common | -$4.58M | -$6.16M | -$152.59M | -$665K | -$776K | -$1.3M |
Shares Outstanding (Basic) | 230.21M | - | 201.69M | 240.08M | - | 240.08M |
Shares Outstanding (Diluted) | 230.21M | - | 201.69M | 240.08M | - | 240.08M |
EPS (Basic) | -$0.02 | - | -$0.76 | -$0.0028 | - | -$0.0054 |
EPS (Diluted) | -$0.02 | - | -$0.76 | -$0.0028 | - | -$0.0054 |
EBIT | -$4.58M | -$6.16M | -$152.59M | -$665K | -$776K | -$1.3M |
EBITDA | -$4.58M | -$6.16M | -$152.59M | -$665K | -$776K | -$1.3M |